Stocks
Funds
Screener
Sectors
Watchlists
XOMA

XOMA - XOMA Corp Stock Price, Fair Value and News

$24.61-1.10 (-4.28%)
Market Closed

47/100

XOMA

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

47/100

XOMA

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$23.84

Target 3M

$25.95

Target 6M

$25.23

XOMA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

XOMA Price Action

Last 7 days

-9.7%

Last 30 days

-2.5%

Last 90 days

-25.9%

Trailing 12 Months

-7.1%

XOMA RSI Chart

XOMA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

XOMA Valuation

Market Cap

304.7M

Price/Earnings (Trailing)

14.08

Price/Sales (Trailing)

6.47

EV/EBITDA

-62.62

Price/Free Cashflow

55.72

XOMA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$23.84

Target 3M

$25.95

Target 6M

$25.23

XOMA Fundamentals

XOMA Revenue

Revenue (TTM)

47.1M

Rev. Growth (Yr)

29.93%

Rev. Growth (Qtr)

-28.78%

XOMA Earnings

Earnings (TTM)

21.6M

Earnings Growth (Yr)

181.49%

Earnings Growth (Qtr)

52.88%

XOMA Profitability

Operating Margin

99.73%

EBT Margin

-41.35%

Return on Equity

24.61%

Return on Assets

8.22%

Free Cashflow Yield

1.79%

XOMA Investor Care

Shares Dilution (1Y)

5.10%

Diluted EPS (TTM)

0.96

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202542.9M45.0M47.1M0
20245.8M15.2M21.6M28.5M
20233.4M4.0M4.4M4.8M
202240.9M41.0M40.5M6.0M
202131.6M33.8M36.0M38.2M
202011.0M10.5M2.2M29.4M
201913.0M11.7M19.6M18.4M
201840.8M29.0M17.1M5.3M
201717.3M29.1M40.9M52.7M
201656.8M54.7M53.2M5.6M
201518.1M14.7M11.6M55.4M
201429.4M28.2M27.1M18.9M
201333.4M31.2M30.3M35.5M
201252.5M45.2M36.2M33.8M
201143.3M52.6M57.9M58.2M
201000033.6M
XOMA
XOMA Corporation operates as a biotech royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets. The company was incorporated in 1981 and is headquartered in Emeryville, California.
 CEO
 WEBSITExoma.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES11

XOMA Corp Frequently Asked Questions


XOMA is the stock ticker symbol of XOMA Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of XOMA Corp is 304.75 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check XOMA's fair value in chart for subscribers.

The fair value guage provides a quick view whether XOMA is over valued or under valued. Whether XOMA Corp is cheap or expensive depends on the assumptions which impact XOMA Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for XOMA.

As of Wed Jan 28 2026, XOMA's PE ratio (Price to Earnings) is 14.08 and Price to Sales (PS) ratio is 6.47. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. XOMA PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, XOMA Corp has provided 0.02 (multiply by 100 for percentage) rate of return.